SAK-3 (Tohoku University)

N/A

Report date: 2025/02/28 11:25:03

NME

Base Information

Drug NameSAK-3 (Tohoku University)

Drug Alias NameSAK-3

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionProteasome stimulantsVoltage-gated T-type calcium channel activatorsCalcium/calmodulin-dependent protein kinase type II subunit gamma stimulants

TargetsCalcium/calmodulin-dependent protein kinase type II subunit gammaVoltage-gated T-type calcium channelProteasome

Therapy Area/IndicationsAlzheimer Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryJapan

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesTohoku University

China Registration ClassN/A

Develop Information

Active CompaniesTohoku University

Inactive CompaniesN/A

Active IndicationsAlzheimer Disease

Inactive IndicationsN/A

Other Information

ATC CodeN/A